35547584|t|Chronic Elevation of Skeletal Muscle [Ca2+]i Impairs Glucose Uptake. An in Vivo and in Vitro Study.
35547584|a|Skeletal muscle is the primary site of insulin-mediated glucose uptake through the body and, therefore, an essential contributor to glucose homeostasis maintenance. We have recently provided evidence that chronic elevated intracellular Ca2+ concentration at rest [(Ca2+)i] compromises glucose homeostasis in malignant hyperthermia muscle cells. To further investigate how chronic elevated muscle [Ca2+]i modifies insulin-mediated glucose homeostasis, we measured [Ca2+]i and glucose uptake in vivo and in vitro in intact polarized muscle cells from glucose-intolerant RYR1-p.R163C and db/db mice. Glucose-intolerant RYR1-p.R163C and db/db mice have significantly elevated muscle [Ca2+]i and reduced muscle glucose uptake compared to WT muscle cells. Dantrolene treatment (1.5 mg/kg IP injection for 2 weeks) caused a significant reduction in fasting blood glucose levels and muscle [Ca2+]i and increased muscle glucose uptake compared to untreated RYR1-p.R163C and db/db mice. Furthermore, RYR1-p.R163C and db/db mice had abnormal basal insulin levels and response to glucose-stimulated insulin secretion. In vitro experiments conducted on single muscle fibers, dantrolene improved insulin-mediated glucose uptake in RYR1-p.R163C and db/db muscle fibers without affecting WT muscle fibers. In muscle cells with chronic elevated [Ca2+]i, GLUT4 expression was significantly lower, and the subcellular fraction (plasma membrane/cytoplasmic) was abnormal compared to WT. The results of this study suggest that i) Chronic elevated muscle [Ca2+]i decreases insulin-stimulated glucose uptake and consequently causes hyperglycemia; ii) Reduced muscle [Ca2+]i by dantrolene improves muscle glucose uptake and subsequent hyperglycemia; iii) The mechanism by which chronic high levels of [Ca2+]i interfere with insulin action appears to involve the expression of GLUT4 and its subcellular fractionation.
35547584	38	42	Ca2+	Chemical	-
35547584	53	60	Glucose	Chemical	MESH:D005947
35547584	156	163	glucose	Chemical	MESH:D005947
35547584	232	239	glucose	Chemical	MESH:D005947
35547584	336	340	Ca2+	Chemical	-
35547584	365	369	Ca2+	Chemical	-
35547584	385	392	glucose	Chemical	MESH:D005947
35547584	408	430	malignant hyperthermia	Disease	MESH:D008305
35547584	497	501	Ca2+	Chemical	-
35547584	530	537	glucose	Chemical	MESH:D005947
35547584	564	568	Ca2+	Chemical	-
35547584	575	582	glucose	Chemical	MESH:D005947
35547584	649	656	glucose	Chemical	MESH:D005947
35547584	668	672	RYR1	Gene	20190
35547584	673	680	p.R163C	ProteinMutation	tmVar:p|SUB|R|163|C;HGVS:p.R163C;VariantGroup:0;OriginalGene:20190;CorrespondingGene:6261;RS#:118192161;CorrespondingSpecies:10090;CA#:18598
35547584	691	695	mice	Species	10090
35547584	697	704	Glucose	Chemical	MESH:D005947
35547584	716	720	RYR1	Gene	20190
35547584	721	728	p.R163C	ProteinMutation	tmVar:p|SUB|R|163|C;HGVS:p.R163C;VariantGroup:0;OriginalGene:20190;CorrespondingGene:6261;RS#:118192161;CorrespondingSpecies:10090;CA#:18598
35547584	739	743	mice	Species	10090
35547584	780	784	Ca2+	Chemical	-
35547584	806	813	glucose	Chemical	MESH:D005947
35547584	850	860	Dantrolene	Chemical	MESH:D003620
35547584	956	963	glucose	Chemical	MESH:D005947
35547584	983	987	Ca2+	Chemical	-
35547584	1011	1018	glucose	Chemical	MESH:D005947
35547584	1048	1052	RYR1	Gene	20190
35547584	1053	1060	p.R163C	ProteinMutation	tmVar:p|SUB|R|163|C;HGVS:p.R163C;VariantGroup:0;OriginalGene:20190;CorrespondingGene:6261;RS#:118192161;CorrespondingSpecies:10090;CA#:18598
35547584	1071	1075	mice	Species	10090
35547584	1090	1094	RYR1	Gene	20190
35547584	1095	1102	p.R163C	ProteinMutation	tmVar:p|SUB|R|163|C;HGVS:p.R163C;VariantGroup:0;OriginalGene:20190;CorrespondingGene:6261;RS#:118192161;CorrespondingSpecies:10090;CA#:18598
35547584	1113	1117	mice	Species	10090
35547584	1168	1175	glucose	Chemical	MESH:D005947
35547584	1262	1272	dantrolene	Chemical	MESH:D003620
35547584	1299	1306	glucose	Chemical	MESH:D005947
35547584	1317	1321	RYR1	Gene	20190
35547584	1322	1329	p.R163C	ProteinMutation	tmVar:p|SUB|R|163|C;HGVS:p.R163C;VariantGroup:0;OriginalGene:20190;CorrespondingGene:6261;RS#:118192161;CorrespondingSpecies:10090;CA#:18598
35547584	1429	1433	Ca2+	Chemical	-
35547584	1437	1442	GLUT4	Gene	20528
35547584	1634	1638	Ca2+	Chemical	-
35547584	1670	1677	glucose	Chemical	MESH:D005947
35547584	1709	1722	hyperglycemia	Disease	MESH:D006943
35547584	1744	1748	Ca2+	Chemical	-
35547584	1754	1764	dantrolene	Chemical	MESH:D003620
35547584	1781	1788	glucose	Chemical	MESH:D005947
35547584	1811	1824	hyperglycemia	Disease	MESH:D006943
35547584	1878	1882	Ca2+	Chemical	-
35547584	1952	1957	GLUT4	Gene	20528
35547584	Association	MESH:D005947	RS#:118192161;HGVS:p.R163C;CorrespondingGene:6261
35547584	Association	MESH:D005947	20190
35547584	Association	MESH:D005947	MESH:D008305
35547584	Positive_Correlation	MESH:D003620	MESH:D006943
35547584	Negative_Correlation	MESH:D003620	MESH:D005947

